Albert Lin is a seasoned business development and healthcare professional with expertise in Rare Disease, Neurology, and Physical Medicine & Rehabilitation. Currently serving as a Senior Business Director at Eli Lilly, Lin has held various roles, including Sr. Territory Business Manager for Alzheimer's Disease at Biogen and Clinical Science Associate at Saol Therapeutics. Prior experience includes positions at Grifols and Steelcase, showcasing a strong background in business strategy and clinical management. Lin earned a Bachelor of Science in Occupational Therapy from the University of Alberta and an MBA in Finance from Pepperdine University.
This person is not in any teams
This person is not in any offices